BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 37969589)

  • 1. A flexible data-free framework for structure-based
    Du H; Jiang D; Zhang O; Wu Z; Gao J; Zhang X; Wang X; Deng Y; Kang Y; Li D; Pan P; Hsieh CY; Hou T
    Chem Sci; 2023 Nov; 14(43):12166-12181. PubMed ID: 37969589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. De Novo Drug Design Using Transformer-Based Machine Translation and Reinforcement Learning of an Adaptive Monte Carlo Tree Search.
    Ang D; Rakovski C; Atamian HS
    Pharmaceuticals (Basel); 2024 Jan; 17(2):. PubMed ID: 38399376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of structure- and ligand-based scoring functions for deep generative models: a GPCR case study.
    Thomas M; Smith RT; O'Boyle NM; de Graaf C; Bender A
    J Cheminform; 2021 May; 13(1):39. PubMed ID: 33985583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FSM-DDTR: End-to-end feedback strategy for multi-objective De Novo drug design using transformers.
    Monteiro NRC; Pereira TO; Machado ACD; Oliveira JL; Abbasi M; Arrais JP
    Comput Biol Med; 2023 Sep; 164():107285. PubMed ID: 37557054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-based
    Li Y; Pei J; Lai L
    Chem Sci; 2021 Oct; 12(41):13664-13675. PubMed ID: 34760151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Equivariant score-based generative diffusion framework for 3D molecules.
    Zhang H; Liu Y; Liu X; Wang C; Guo M
    BMC Bioinformatics; 2024 May; 25(1):203. PubMed ID: 38816718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. De novo molecular design with deep molecular generative models for PPI inhibitors.
    Wang J; Chu Y; Mao J; Jeon HN; Jin H; Zeb A; Jang Y; Cho KH; Song T; No KT
    Brief Bioinform; 2022 Jul; 23(4):. PubMed ID: 35830870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LOGICS: Learning optimal generative distribution for designing de novo chemical structures.
    Bae B; Bae H; Nam H
    J Cheminform; 2023 Sep; 15(1):77. PubMed ID: 37674239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNMG: Deep molecular generative model by fusion of 3D information for de novo drug design.
    Song T; Ren Y; Wang S; Han P; Wang L; Li X; Rodriguez-Patón A
    Methods; 2023 Mar; 211():10-22. PubMed ID: 36764588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RELATION: A Deep Generative Model for Structure-Based De Novo Drug Design.
    Wang M; Hsieh CY; Wang J; Wang D; Weng G; Shen C; Yao X; Bing Z; Li H; Cao D; Hou T
    J Med Chem; 2022 Jul; 65(13):9478-9492. PubMed ID: 35713420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Artificial Intelligence-Enabled De Novo Design of Novel Compounds that Are Synthesizable.
    Bhisetti G; Fang C
    Methods Mol Biol; 2022; 2390():409-419. PubMed ID: 34731479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Augmented Hill-Climb increases reinforcement learning efficiency for language-based de novo molecule generation.
    Thomas M; O'Boyle NM; Bender A; de Graaf C
    J Cheminform; 2022 Oct; 14(1):68. PubMed ID: 36192789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multi-objective de novo drug design with conditional graph generative model.
    Li Y; Zhang L; Liu Z
    J Cheminform; 2018 Jul; 10(1):33. PubMed ID: 30043127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of scoring-assisted generative exploration (SAGE) and its application to dual inhibitor design for acetylcholinesterase and monoamine oxidase B.
    Lim H
    J Cheminform; 2024 May; 16(1):59. PubMed ID: 38790018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An equivariant generative framework for molecular graph-structure Co-design.
    Zhang Z; Liu Q; Lee CK; Hsieh CY; Chen E
    Chem Sci; 2023 Aug; 14(31):8380-8392. PubMed ID: 37564414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FAME: Fragment-based Conditional Molecular Generation for Phenotypic Drug Discovery.
    Pham TH; Xie L; Zhang P
    Proc SIAM Int Conf Data Min; 2022; 2022():720-728. PubMed ID: 35509686
    [No Abstract]   [Full Text] [Related]  

  • 17.
    Atance SR; Diez JV; Engkvist O; Olsson S; Mercado R
    J Chem Inf Model; 2022 Oct; 62(20):4863-4872. PubMed ID: 36219571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. De novo generation of dual-target ligands using adversarial training and reinforcement learning.
    Lu F; Li M; Min X; Li C; Zeng X
    Brief Bioinform; 2021 Nov; 22(6):. PubMed ID: 34410338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances and Challenges in De Novo Drug Design Using Three-Dimensional Deep Generative Models.
    Xie W; Wang F; Li Y; Lai L; Pei J
    J Chem Inf Model; 2022 May; 62(10):2269-2279. PubMed ID: 35544331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecule generation toward target protein (SARS-CoV-2) using reinforcement learning-based graph neural network via knowledge graph.
    Ranjan A; Kumar H; Kumari D; Anand A; Misra R
    Netw Model Anal Health Inform Bioinform; 2023; 12(1):13. PubMed ID: 36627927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.